EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Review of Psilocybin Use for Depression among Cancer Patients after Approval in Oregon

Val Bellman iD

Cancers · 27.04.2024 · 16 (9) · 1702

DOI: 10.3390/cancers16091702 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 27.04.2024. Verfasst von Val Bellman. Beteiligte Einrichtung: Psychiatry Residency Training Program, University of Missouri Kansas City, Kansas City, MO 64108, USA. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the legalization of psilocybin therapy for depression in terminal illnesses such as advanced cancer through Oregon’s Measure 109 in 2020, significant challenges have impeded its implementation. This review synthesizes the empirical data supporting the utilization of psilocybin therapy for addressing cancer-related depression, including an evaluation of its purported benefits and potential adverse effects. It provides a comprehensive examination of therapeutic strategies, dosing regimens, and barriers to ensuring responsible and equitable access. Salient issues explored include the development of ethical protocols, integration within healthcare systems, ensuring statewide availability, resolving legal ambiguities, and defining clinical standards. Oregon’s pioneering role serves as a case study, highlighting the necessity of addressing regulatory, logistical, and ethical obstacles to ensure the establishment of rigorous and equitable psilocybin care models.

Schlagwörter

Stichwörter der Autor:innen

Oregoncancerdepressionend-of-life carepsilocybin

Autor:innen und Institutionen

  • Psychiatry Residency Training Program, University of Missouri Kansas City, Kansas City, MO 64108, USA.

ORCID-Profile: Val Bellman

Zitieren

APA

Bellman, V. (2024). Review of Psilocybin Use for Depression among Cancer Patients after Approval in Oregon. Cancers, 16(9), 1702. https://doi.org/10.3390/cancers16091702

Vancouver

Bellman V. Review of Psilocybin Use for Depression among Cancer Patients after Approval in Oregon. Cancers. 2024;16(9):1702. doi:10.3390/cancers16091702

BibTeX
@article{Bellman2024,
  author = {Bellman, Val},
  title = {Review of Psilocybin Use for Depression among Cancer Patients after Approval in Oregon},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {9},
  pages = {1702},
  doi = {10.3390/cancers16091702}
}
Kostenlos starten →